Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NewLeaf Symbiotics acquires Intuitive Genomics

The US agricultural biotechnology company, NewLeaf Symbiotics (St Louis, Missouri), has acquired US genomics firm Intuitive Genomics (St Louis, Missouri). Both companies are based at the Donald Danforth Plant Science Center. NewLeaf is seeking to commercialise naturally beneficial plant bacteria for crop health and protection. The use of natural biologicals to control plant disease and increase crop yield is "one of the most promising opportunities to address the rapidly expanding global agricultural productivity gap", NewLeaf states. The acquisition of Intuitive Genomics' computational and bioinformatics capabilities complements NewLeaf's R&D and product pipeline and positions the company as "a top player in the burgeoning biologicals category", it adds. NewLeaf was founded by a group of entrepreneurs and former Monsanto scientists and executives. It is researching pink pigmented facultative methylotrophs and is the exclusive licensee of several patents on the use of these bacteria.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG000783

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel